Arene ruthenium complexes as anticancer agents (Q39706669)

14 September 2017

Arene ruthenium complexes as anticancer agents (English)

1 reference

14 September 2017

1 reference

1

Georg Süss-Fink

1 reference

PubMed ID

20449402

14 September 2017

language of work or name

English

0 references

publication date

23 October 2009

1 reference

14 September 2017

1 reference

14 September 2017

39

1 reference

14 September 2017

7

1 reference

14 September 2017

1673-1688

1 reference

Ruthenium Anticancer Compounds: Challenges and Expectations

14 September 2017

1 reference

Platinum Compounds: a New Class of Potent Antitumour Agents

21 January 2018

1 reference

Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins

21 January 2018

1 reference

Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches

21 January 2018

1 reference

Metal based drugs: from serendipity to design

21 January 2018

1 reference

Ruthenium complexes as anticancer agents

21 January 2018

1 reference

Metal-based antitumour drugs in the post genomic era.

21 January 2018

1 reference

Synthesis, Structure and Antitumour Properties of a New 1,2-Propylenediaminetetraacetate-Ruthenium(III) Compound

21 January 2018

1 reference

Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline.

21 January 2018

1 reference

Structure-dependent in vitro cytotoxicity of the isomeric complexes [Ru(L)2Cl2] (L= o-tolylazopyridine and 4-methyl-2-phenylazopyridine) in comparison to [Ru(azpy)2Cl2].

21 January 2018

1 reference

Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A.

21 January 2018

1 reference

Bioorganometallic chemistry--from teaching paradigms to medicinal applications

21 January 2018

1 reference

Inhibition of cancer cell growth by ruthenium(II) arene complexes

21 January 2018

1 reference

In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes

21 January 2018

1 reference

Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis

21 January 2018

1 reference

Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity

21 January 2018

1 reference

CZE-ICP-MS as a tool for studying the hydrolysis of ruthenium anticancer drug candidates and their reactivity towards the DNA model compound dGMP.

21 January 2018

1 reference

Studies on the reactivity of organometallic Ru-, Rh- and Os-pta complexes with DNA model compounds

21 January 2018

1 reference

Half-sandwich arene ruthenium(II)-enzyme complex

21 January 2018

1 reference

Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds

21 January 2018

1 reference

The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways

21 January 2018

1 reference

In vitro anticancer activity and biologically relevant metabolization of organometallic ruthenium complexes with carbohydrate-based ligands

21 January 2018

1 reference

Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets

21 January 2018

1 reference

Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance.

21 January 2018

1 reference

Rational design of an organometallic glutathione transferase inhibitor

21 January 2018

1 reference

Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology.

21 January 2018

1 reference

Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells.

21 January 2018

1 reference

Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms

21 January 2018

1 reference

Organometallic ruthenium inhibitors of glutathione-S-transferase P1-1 as anticancer drugs

21 January 2018

1 reference

Synthesis, characterization, and in vitro antimalarial and antitumor activity of new ruthenium(II) complexes of chloroquine

21 January 2018

1 reference

In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer

21 January 2018

1 reference

Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts.

21 January 2018

1 reference

Ruthenation of duplex and single-stranded d(CGGCCG) by organometallic anticancer complexes

21 January 2018

1 reference

Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms.

21 January 2018

1 reference

Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts

21 January 2018

1 reference

DNA Interactions of Monofunctional Organometallic Ruthenium(II) Antitumor Complexes in Cell-free Media

21 January 2018

1 reference

Reactions of a ruthenium(II) arene antitumor complex with cysteine and methionine

21 January 2018

1 reference

Competitive reactions of a ruthenium arene anticancer complex with histidine, cytochrome c and an oligonucleotide

21 January 2018

1 reference

Competition between glutathione and guanine for a ruthenium(II) arene anticancer complex: detection of a sulfenato intermediate

21 January 2018

1 reference

106Ru radiolabelling of the antitumour complex [(eta6-fluorene)Ru(en)Cl]PF6.

21 January 2018

1 reference

Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands.

21 January 2018

1 reference

The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.

21 January 2018

1 reference

Catalytic organometallic anticancer complexes

21 January 2018

1 reference

Journal club. A chemist highlights promising organometallic drugs

21 January 2018

1 reference

Modifying the structure of dinuclear ruthenium complexes with antitumor activity

21 January 2018

1 reference

Ferrocenoyl pyridine arene ruthenium complexes with anticancer properties: synthesis, structure, electrochemistry, and cytotoxicity

21 January 2018

1 reference

Transferring the concept of multinuclearity to ruthenium complexes for improvement of anticancer activity

21 January 2018

1 reference

Ruthenium porphyrin compounds for photodynamic therapy of cancer

21 January 2018

1 reference

The "complex-in-a-complex" cations [(acac)2M subset Ru6(p-iPrC6H4Me)6(tpt)2(dhbq)3]6+: A trojan horse for cancer cells

21 January 2018

1 reference

ESI–MS Characterisation of Protein Adducts of Anticancer Ruthenium(II)-Arene PTA (RAPTA) Complexes

21 January 2018

1 reference

Systematic Design of a Targeted Organometallic Antitumour Drug in Pre-clinical Development

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.2533/CHIMIA.2007.698

Transition metal carbonyl oestrogen receptor assay

8 July 2023

1 reference

20 August 2023

https://opencitations.net/index/coci/api/v1/citations/10.1351/PAC198557121865

Identifiers

DOI

10.1039/B916860P

1 reference

release_jd76glvn4bac5ldzpux4kv3zje

14 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jd76glvn4bac5ldzpux4kv3zje

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

20449402

1 reference

PubMed ID

20449402